Glenmark Pharmaceuticals receives final approval for Olmesartan Medoxomil

From USFDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar Tablets, 5 mg, 20 mg and 40 mg, of Daiichi Sankyo, Inc. Glenmark's Olmesartan Medoxomil Tablets will be manufactured by Glenmark Pharmaceuticals Limited in its manufacturing facility located in Goa, India.

Powered by Capital Market - Live News